Kenneth I. Weinberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kenneth I. Weinberg has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Bernstein
Department of Pediatrics, Stanford University School of Medicine, Stanford, USA
2 shared publications - Matthew Hebden Porteus
Stanford University
2 shared publications - Adam E. Handel
Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford , Oxford, OX3 9DU
1 shared publication Akin Tekin
Miller School of Medicine, University of Medicine, Florida, USA
1 shared publication- Alan R. Schroeder
Department of Pediatrics, Stanford University School of Medicine, 453 Quarry Road, Palo Alto CA 94304
1 shared publication Aleishia Harris-Arnold
Department of Surgery, Stanford University School of Medicine, Palo Alto, California, USA; Stanford Immunology, Stanford University School of Medicine, Palo Alto, California, USA
1 shared publication
Latest Publications
- Open Access
- 29 January 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1328005
Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition
Biallelic mutations in the ACP5 gene cause spondyloenchondrodysplasia with immune dysregulation (SPENCDI). SPENCDI is characterized by the phenotypic triad of skeletal dysplasia, innate and adaptive immune dysfunction, and variable neurologic findings ranging from asymptomatic brain calcifications to severe developmental delay with spasticity. Immune dysregulation in SPENCDI is often refractory to standard immunosuppressive treatments. Here, we present the cases of two patients with SPENCDI and recalcitrant autoimmune cytopenias who demonstrated a favorable clinical response to targeted JAK inhibition over a period of more than 3 years. One of the patients exhibited steadily rising IgG levels and a bone marrow biopsy revealed smoldering multiple myeloma. A review of the literature uncovered that approximately half of the SPENCDI patients reported to date exhibited increased IgG levels. Screening for multiple myeloma in SPENCDI patients with rising IgG levels should therefore be considered.
- 29 January 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1328005
Open AccessCase report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition
Biallelic mutations in the ACP5 gene cause spondyloenchondrodysplasia with immune dysregulation (SPENCDI). SPENCDI is characterized by the phenotypic triad of skeletal dysplasia, innate and adaptive immune dysfunction, and variable neurologic findings ranging from asymptomatic brain calcifications to severe developmental delay with spasticity. Immune dysregulation in SPENCDI is often refractory to standard immunosuppressive treatments. Here, we present the cases of two patients with SPENCDI and recalcitrant autoimmune cytopenias who demonstrated a favorable clinical response to targeted JAK inhibition over a period of more than 3 years. One of the patients exhibited steadily rising IgG levels and a bone marrow biopsy revealed smoldering multiple myeloma. A review of the literature uncovered that approximately half of the SPENCDI patients reported to date exhibited increased IgG levels. Screening for multiple myeloma in SPENCDI patients with rising IgG levels should therefore be considered.
- Open Access
- 15 February 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 611-618
Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
- 15 February 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 611-618
Open AccessMutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
- 21 June 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (8) , e14344
Fatal nocardiosis infection in a pediatric patient with an immunodeficiency after heart re‐transplantation
Background: Nocardia infections are rare opportunistic infections in SOT recipients, with few reported pediatric cases. Pediatric patients with single ventricle congenital heart defects requiring HT may be more susceptible to opportunistic infections due to a decreased T‐cell repertoire from early thymectomy and potential immunodeficiencies related to their congenital heart disease. Other risk factors in SOT recipients include the use of immunosuppressive medications and the development of persistent lymphopenia, delayed count recovery and/or lymphocyte dysfunction.Methods: We report the case of a patient with hypoplastic left heart syndrome who underwent neonatal congenital heart surgery (with thymectomy) prior to palliative surgery and 2 HTs.Results: After developing respiratory and neurological symptoms, the patient was found to be positive for Nocardia farcinica by BAL culture and cerebrospinal fluid PCR. Immune cell phenotyping demonstrated an attenuated T and B‐cell repertoire. Despite antibiotic and immunoglobulin therapy, his symptoms worsened and he was subsequently discharged with hospice care.Conclusion: Pediatric patients with a history of congenital heart defects who undergo neonatal thymectomy prior to heart transplantation and a long‐term history of immunosuppression should undergo routine immune system profiling to evaluate for T‐ and B‐cell deficiency as risk factors for opportunistic infection. Such patients could benefit from long‐term therapy with TMP/SMX for optimal antimicrobial prophylaxis, with desensitization as needed for allergies. Disseminated nocardiosis should be considered when evaluating acutely ill SOT recipients, especially those with persistent lymphopenia and known or suspected secondary immunodeficiencies.
- 21 June 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (8) , e14344
Fatal nocardiosis infection in a pediatric patient with an immunodeficiency after heart re‐transplantation
Background: Nocardia infections are rare opportunistic infections in SOT recipients, with few reported pediatric cases. Pediatric patients with single ventricle congenital heart defects requiring HT may be more susceptible to opportunistic infections due to a decreased T‐cell repertoire from early thymectomy and potential immunodeficiencies related to their congenital heart disease. Other risk factors in SOT recipients include the use of immunosuppressive medications and the development of persistent lymphopenia, delayed count recovery and/or lymphocyte dysfunction.Methods: We report the case of a patient with hypoplastic left heart syndrome who underwent neonatal congenital heart surgery (with thymectomy) prior to palliative surgery and 2 HTs.Results: After developing respiratory and neurological symptoms, the patient was found to be positive for Nocardia farcinica by BAL culture and cerebrospinal fluid PCR. Immune cell phenotyping demonstrated an attenuated T and B‐cell repertoire. Despite antibiotic and immunoglobulin therapy, his symptoms worsened and he was subsequently discharged with hospice care.Conclusion: Pediatric patients with a history of congenital heart defects who undergo neonatal thymectomy prior to heart transplantation and a long‐term history of immunosuppression should undergo routine immune system profiling to evaluate for T‐ and B‐cell deficiency as risk factors for opportunistic infection. Such patients could benefit from long‐term therapy with TMP/SMX for optimal antimicrobial prophylaxis, with desensitization as needed for allergies. Disseminated nocardiosis should be considered when evaluating acutely ill SOT recipients, especially those with persistent lymphopenia and known or suspected secondary immunodeficiencies.
- Open Access
- 13 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (19) , eabm9844
Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
The thymic stroma is composed of epithelial and nonepithelial cells providing separate microenvironments controlling homing, differentiation, and selection of hematopoietic precursor cells to functional T cells. Here, we explore at single-cell resolution the complex composition and dynamic changes of the nonepithelial stromal compartment across different developmental stages in the human and mouse thymus, and in an experimental model of the DiGeorge syndrome, the most common form of human thymic hypoplasia. The detected gene expression signatures identify previously unknown stromal subtypes and relate their individual molecular profiles to separate differentiation trajectories and functions, revealing an unprecedented heterogeneity of different cell types that emerge at discrete developmental stages and vary in their expression of key regulatory signaling circuits and extracellular matrix components. Together, these findings highlight the dynamic complexity of the nonepithelial thymus stroma and link this to separate instructive roles essential for normal thymus organogenesis and tissue maintenance.
- 13 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (19) , eabm9844
Open AccessDevelopmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
The thymic stroma is composed of epithelial and nonepithelial cells providing separate microenvironments controlling homing, differentiation, and selection of hematopoietic precursor cells to functional T cells. Here, we explore at single-cell resolution the complex composition and dynamic changes of the nonepithelial stromal compartment across different developmental stages in the human and mouse thymus, and in an experimental model of the DiGeorge syndrome, the most common form of human thymic hypoplasia. The detected gene expression signatures identify previously unknown stromal subtypes and relate their individual molecular profiles to separate differentiation trajectories and functions, revealing an unprecedented heterogeneity of different cell types that emerge at discrete developmental stages and vary in their expression of key regulatory signaling circuits and extracellular matrix components. Together, these findings highlight the dynamic complexity of the nonepithelial thymus stroma and link this to separate instructive roles essential for normal thymus organogenesis and tissue maintenance.
- Open Access
- 26 April 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
The original version of this Article omitted the following from the Acknowledgements: “G.B. acknowledges the support from the Cancer Prevention and Research Institute of Texas (RR140081 and RR170721).”This has now been corrected in both the PDF and HTML versions of the Article.
- 26 April 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1
Open AccessAuthor Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
The original version of this Article omitted the following from the Acknowledgements: “G.B. acknowledges the support from the Cancer Prevention and Research Institute of Texas (RR140081 and RR170721).”This has now been corrected in both the PDF and HTML versions of the Article.
- Open Access
- 1 February 2014
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 20 (2) , S255
END Organ Disease in the Context of Human Herpes VIRUS 6 Viremia in Pediatric Allogeneic Hematopoietic STEM CELL Transplant Patients: A Case Series
- 1 February 2014
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 20 (2) , S255
Open AccessEND Organ Disease in the Context of Human Herpes VIRUS 6 Viremia in Pediatric Allogeneic Hematopoietic STEM CELL Transplant Patients: A Case Series
- Open Access
- 19 November 2010
- Published by American Society of Hematology in Blood
- Vol. 116 (21) , 1496
Paradoxical Dose-Dependent Chemoattractive and Chemorepellent Effects of Kit Ligand (KL) In Mast Cells Revealed In Novel Microfluidic Biochambers.
Abstract 1496 Besides its cooperating effects on stem cell proliferation and survival, KL (stem cell factor) is a potent chemotactic protein; much of the Kit (-) phenotype is related to loss of chemotaxis of progenitor cells. While transwell assays permit studies of the frequency of migrating cells, the lack of direct visualization during chemotaxis precludes dynamic or detailed studies of cell behavior. We have developed microfluidic biochambers fabricated from optically clear plastic with microcapillaries continuously perfused from source and sink channels to create stable ligand gradients of desired concentration and steepness without mechanical shear forces. We have analyzed KL-induced chemotaxis, using Kit+ cultured murine bone marrow-derived mast cells (BMMC) as a model. BMMC were plated onto fibronectin coated chambers and two linear KL equilibrium concentration profiles were tested (gradients of 4 and 8 ng/ml/mm across a concentration range of 1.5–11 ng/ml) for their ability to induce BMMC chemotaxis. Cell movement and morphology was captured by time-lapse microscopy and quantitatively analyzed for migration rate, frequency and duration of pauses, directional persistence, filopodia extension rate, filopodia asymmetry, and cell perimeter asymmetry. Our results indicate a minimum activating threshold of ∼3 ng/ml is required to induce BMMC chemoattraction. The chemotactic index (CI) is a ratio of distance travelled towards a gradient to total distance travelled (e.g., CI=0 indicates random migration, CI=1 indicates movement in a straight line towards the gradient). Between 3–8 ng/ml, higher KL concentrations resulted in faster cell speed (means 1.0–1.9 μm/min; maximum up to 2.9 μ/min), higher migratory persistence (means 0.2–0.5), higher CI (means 0.05 to 0.42), and greater filopodial formation. Analysis of cells at the lowest KL concentrations revealed a paradoxical chemorepulsive activity, which has not been previously described. The majority of the cells undergo chemorepulsion at KL concentrations 1.5–3 ng/ml. Unlike chemoattraction which was continuous, chemorepulsion only occurs during the first 30–40 minutes of KL stimulation, followed by predominantly random or no migration, i.e., chemorepulsion is followed by a chemotaxis-refractory state. Both chemoattractive and chemorepulsive movements were characterized by filopodia formation on the leading edge of movement. The results with the Kit receptor tyrosine kinase differ significantly from previous studies of G-protein coupled receptors, where chemorepulsion only occurred at high ligand concentrations. The results indicate that Kit-mediated chemotaxis is mainly concentration-dependent; involves complex dose-response relationships; and includes both chemoattractive and chemorepellent phases. Studies of Kit+ hematopoietic stem cells are being performed to determine whether KL chemotactic responses similar to those seen in BMMC are a general phenomenon, which would have major implications for understanding HSC migration, homing and niche relationships, as well as mast cell biology and inflammation.
- 19 November 2010
- Published by American Society of Hematology in Blood
- Vol. 116 (21) , 1496
Open AccessParadoxical Dose-Dependent Chemoattractive and Chemorepellent Effects of Kit Ligand (KL) In Mast Cells Revealed In Novel Microfluidic Biochambers.
Abstract 1496 Besides its cooperating effects on stem cell proliferation and survival, KL (stem cell factor) is a potent chemotactic protein; much of the Kit (-) phenotype is related to loss of chemotaxis of progenitor cells. While transwell assays permit studies of the frequency of migrating cells, the lack of direct visualization during chemotaxis precludes dynamic or detailed studies of cell behavior. We have developed microfluidic biochambers fabricated from optically clear plastic with microcapillaries continuously perfused from source and sink channels to create stable ligand gradients of desired concentration and steepness without mechanical shear forces. We have analyzed KL-induced chemotaxis, using Kit+ cultured murine bone marrow-derived mast cells (BMMC) as a model. BMMC were plated onto fibronectin coated chambers and two linear KL equilibrium concentration profiles were tested (gradients of 4 and 8 ng/ml/mm across a concentration range of 1.5–11 ng/ml) for their ability to induce BMMC chemotaxis. Cell movement and morphology was captured by time-lapse microscopy and quantitatively analyzed for migration rate, frequency and duration of pauses, directional persistence, filopodia extension rate, filopodia asymmetry, and cell perimeter asymmetry. Our results indicate a minimum activating threshold of ∼3 ng/ml is required to induce BMMC chemoattraction. The chemotactic index (CI) is a ratio of distance travelled towards a gradient to total distance travelled (e.g., CI=0 indicates random migration, CI=1 indicates movement in a straight line towards the gradient). Between 3–8 ng/ml, higher KL concentrations resulted in faster cell speed (means 1.0–1.9 μm/min; maximum up to 2.9 μ/min), higher migratory persistence (means 0.2–0.5), higher CI (means 0.05 to 0.42), and greater filopodial formation. Analysis of cells at the lowest KL concentrations revealed a paradoxical chemorepulsive activity, which has not been previously described. The majority of the cells undergo chemorepulsion at KL concentrations 1.5–3 ng/ml. Unlike chemoattraction which was continuous, chemorepulsion only occurs during the first 30–40 minutes of KL stimulation, followed by predominantly random or no migration, i.e., chemorepulsion is followed by a chemotaxis-refractory state. Both chemoattractive and chemorepulsive movements were characterized by filopodia formation on the leading edge of movement. The results with the Kit receptor tyrosine kinase differ significantly from previous studies of G-protein coupled receptors, where chemorepulsion only occurred at high ligand concentrations. The results indicate that Kit-mediated chemotaxis is mainly concentration-dependent; involves complex dose-response relationships; and includes both chemoattractive and chemorepellent phases. Studies of Kit+ hematopoietic stem cells are being performed to determine whether KL chemotactic responses similar to those seen in BMMC are a general phenomenon, which would have major implications for understanding HSC migration, homing and niche relationships, as well as mast cell biology and inflammation.